Oktayoglu, PelinMete, NuriyeKaya, HalideCaglayan, MehmetBozkurt, MehtapNas, Kemal2024-04-242024-04-2420140392-856X1593-098Xhttps://hdl.handle.net/11468/21665[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessCalprotectinSystemic SclerosisDisease ActivityQuality Of LifeElevated Serum Levels of Calprotectin (Mrp8/14) in Patients with Systemic SclerosisElevated Serum Levels of Calprotectin (Mrp8/14) in Patients with Systemic SclerosisConference Object324S69S70WOS:000440319800171Q2